TNDM Q4 2023 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$197M-10.8% YoY

Gross Profit

$93M47.4% margin

Operating Income

-$35M-17.8% margin

Net Income

-$30M-15.2% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

+6.0%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$35M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$953M

Total Liabilities

$639M

Stockholders' Equity

$314M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$197M	$221M	-10.8%
Gross Profit	$93M	$116M	-19.2%
Operating Income	-$35M	-$18M	-97.2%
Net Income	-$30M	-$16M	-89.3%

Geographic Segments

UNITED STATES

$151M77%

Non-US

$46M23%